Zhejiang Conba Pharmaceutical Co.,Ltd. provided earnings guidance for the first half of 2015. For the period, the company predicts an increase of above 50% in the net profit belonging to owners of the parent company compared with that disclosed in the semi-annual report of 2014.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.01 CNY | -3.47% | -4.02% | -0.79% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.79% | 1.76B | |
+15.37% | 41.97B | |
+22.56% | 22.34B | |
+15.04% | 15.25B | |
+16.53% | 14B | |
+49.78% | 12.06B | |
-10.77% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- 600572 Stock
- News Zhejiang CONBA Pharmaceutical Co.,Ltd.
- Zhejiang Conba Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the First Half of 2015